Enliven Therapeutics ELVN
NASDAQ ELVN
$41.93 +0.11 (+0.26%)
At close: Oct 22, 2026 · 4:00 PM EDT

Enliven Therapeutics (ELVN) Other non-cash items (2022 - 2026)

Updated

Analysis

Enliven Therapeutics (ELVN) Other non-cash items (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Enliven Therapeutics 2.78 Bn 491.13 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 126,000.00
Mar 31, 2026 93,000.00
Dec 31, 2025 92,000.00
Sep 30, 2025 89,000.00
Jun 30, 2025 87,000.00
Mar 31, 2025 85,000.00
Dec 31, 2024 81,000.00
Sep 30, 2024 80,000.00
Jun 30, 2024 80,000.00
Mar 31, 2024 79,000.00
Dec 31, 2023 78,000.00
Sep 30, 2023 228,000.00
Sep 30, 2022 12,000.00
API Access

Enliven Therapeutics Other non-cash items API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-cash-items&ticker=ELVN&period=max&api_key=YOUR_API_KEY